648 — SoftMedx Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- HK$552.77m
- HK$574.87m
- HK$54.64m
Annual cashflow statement for SoftMedx Healthcare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -52.5 | -24.7 | -16.6 | 14.4 | 328 |
| Depreciation | |||||
| Non-Cash Items | 22.5 | 3.99 | 9.96 | -5.97 | -318 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 18.4 | 12.9 | 1.79 | -14.1 | -6.34 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.92 | -6.62 | -2.84 | -4.49 | 3.88 |
| Capital Expenditures | 0 | -0.524 | -0.532 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.305 | -0.173 | 0.203 | -0.845 | 0.188 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.305 | -0.697 | -0.329 | -0.845 | 0.188 |
| Financing Cash Flow Items | -0.048 | -0.071 | -0.1 | -0.037 | -0.036 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.33 | 9.91 | 2.6 | 10.3 | -3.36 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.28 | 2.6 | -0.575 | 4.97 | 0.705 |